The Global Tumor-Specific Antigen Market is expected to grow at a compound annual growth rate (CAGR) of 6% for the period of 2022-2028. Antigens produced by tumor cells are called tumor-specific antigens. They are actually cytoplasmic protein derivatives. Tumor antigens have promising cancer treatment potential because they are useful tumor markers for detecting tumor cells […]
